APYX
NASDAQ
US
Apyx Medical Corporation - Common Stock
$3.68
▲ +$0.05
(+1.38%)
Vol 44K
5
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$143.6M
ROE
-153.8%
Margin
-30.4%
D/E
592.44
Beta
1.64
52W
$1–$4
Wall Street Consensus
11 analysts · Apr 20263
Strong Buy
7
Buy
1
Hold
0
Sell
0
Strong Sell
90.9%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 100.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.06 | $-0.03 | +$0.03 |
| Sep 2025 | $-0.10 | $-0.05 | +$0.05 |
| Jun 2025 | $-0.10 | $-0.09 | +$0.01 |
| Mar 2025 | $-0.12 | $-0.10 | +$0.02 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | $14.2M | $9.4M | $11.4M | $12.9M | $19.2M |
| Net Income | — | -$4.6M | -$4.2M | -$3.8M | -$2.0M | -$1.3M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -160.5% | -160.5% | -160.5% | -160.5% | -153.8% | -153.8% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -33.2% | -37.1% | -37.1% | -37.1% | -30.4% | -30.4% |
| Gross Margin | 62.3% | 61.6% | 61.6% | 61.6% | 62.6% | 62.6% |
| D/E Ratio | 474.40 | 474.40 | 474.40 | 474.40 | 592.44 | 592.44 |
| Current Ratio | 4.72 | 4.72 | 4.72 | 4.72 | 4.44 | 4.44 |
Key Ratios
ROA (TTM)
-24.2%
P/S (TTM)
3.00
P/B
4.5
EPS (TTM)
$-0.36
CF/Share
$-0.42
Rev Growth 3Y
-0.3%
52W High
$4.44
52W Low
$0.76
$0.76
52-Week Range
$4.44
Financial Health
Free Cash Flow
-$2.8M
Net Debt
$7.6M
Cash
$31.7M
Total Debt
$39.3M
As of Dec 31, 2025
How does APYX compare to Health Care peers?
Peer group: Micro-cap Health Care (All) · 241 companies
APYX valuation vs Health Care peers
P/E ratio
—
▼
0%
below
peers
(30.7)
vs Peers
vs Industry
Undervalued
P/S ratio
3.0
▲
16%
above
peers
(2.6)
vs Peers
vs Industry
Pricier
P/B ratio
4.5
▲
62%
above
peers
(2.8)
vs Peers
vs Industry
Pricier
Div yield
—
▼
0%
below
peers
(0.7%)
vs Peers
vs Industry
Low yield
APYX profitability vs Health Care peers
ROE
-153.8%
▼
299%
below
peers
(-38.5%)
vs Peers
vs Industry
Weak
Net margin
-30.4%
▼
23%
below
peers
(-24.7%)
vs Peers
vs Industry
Below avg
Gross margin
62.7%
▲
18%
above
peers
(52.9%)
vs Peers
vs Industry
Below avg
ROA
-24.2%
▼
14%
below
peers
(-21.2%)
vs Peers
vs Industry
In line
APYX financial health vs Health Care peers
D/E ratio
592.4
▲
2973%
above
peers
(19.3)
vs Peers
vs Industry
High debt
Current ratio
4.4
▲
106%
above
peers
(2.2)
vs Peers
vs Industry
Strong liquidity
Beta
1.6
▲
56%
above
peers
(1.1)
vs Peers
vs Industry
More volatile
APYX fundamentals radar
APYX
Peer median
Industry
APYX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
APYX vs peers: key metrics
Insider Activity
NeutralBuys
0
Sells
0
CITRONOWICZ MOSHE
Officer · Mar 13
37000 shs
ROMAN SHAWN DAVID
Chief Operating Officer · Jan 27
12000 shs
Last 90 days
Top Holders
Top 5: 29.4%Nantahala Capital Managemen…
9.50%
$14.5M
Archon Capital Management L…
7.68%
$11.7M
Royce & Associates LP
5.84%
$8.9M
Vanguard Group Inc
3.74%
$5.7M
AIGH Capital Management LLC
2.64%
$4.0M
As of Dec 31, 2025
Latest News
No related news yet